NYT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the provided data, New York Times Co (NYT) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and Buffett's recent investment in the stock make it a compelling choice despite minor insider selling and slightly negative pre-market movement.
The technical indicators for NYT are generally bullish. The MACD is above 0 and positively contracting, suggesting upward momentum. The RSI is neutral at 58.722, indicating no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading above the key pivot level of 81.727. Resistance levels are at 84.68 and 86.504, while support levels are at 78.774 and 76.95.
Warren Buffett recently initiated a new investment in New York Times, signaling confidence in the company's future.
The company's Q4 financials show strong growth in revenue (+10.42% YoY), net income (+4.94% YoY), EPS (+5.41% YoY), and gross margin (+2.08% YoY).
Analysts have raised price targets recently, with Citi increasing its target to $94 and maintaining a Buy rating, citing positive digital pivot and improving advertising trends.
Insider selling has increased significantly by 1155.15% over the last month, which may indicate some caution among company insiders.
The pre-market price is down slightly by -0.11%, and the broader S&P 500 is also slightly negative (-0.05%).
In Q4 2025, New York Times reported strong financial performance. Revenue increased by 10.42% YoY to $802.31 million, net income rose by 4.94% YoY to $129.84 million, EPS grew by 5.41% YoY to 0.78, and gross margin improved by 2.08% YoY to 51.63%. This demonstrates solid growth and operational efficiency.
Analysts are generally bullish on NYT. Citi recently raised its price target to $94 from $77 and maintained a Buy rating, citing strong digital pivot and advertising trends. Other analysts, including JPMorgan and Evercore ISI, have also raised price targets and maintained positive ratings. However, Guggenheim and Barclays have more neutral stances with lower price targets.
